Search research articles
Contact Us
Filters
Showing results (411-420 of 575) with videos related to
Page
of 58
Sort By:
Journal of Oncology
|
January 3, 2022
Clinicopathologic Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer
Ying Liu, Yu-Ping Zhou, Mai Zhang, et al.
Thoracic Cancer
|
October 22, 2016
Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes
Bingwen Zou, Jing Pang, Yongmei Liu, et al.
Thoracic Cancer
|
September 19, 2017
Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case-control study
Daxian Luo, Meijuan Huang, Xinxing Zhang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
April 28, 2021
Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches
Ting Mei, Weigang Xiu, Xuexi Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 29, 2025
Successful Pregnancy and Healthy Baby Outcome in a Patient With Tyrosine Kinase Inhibitor-Refractory ALK-Positive NSCLC and Central Nervous System Metastasis Treated With Lorlatinib With Maternal-Fetal Pharmacokinetics and Child Milestone Development Correlations
Zhuoran Yao, Min Tang, Ying Jin, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
October 12, 2025
Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study
Yuan Cheng, Jun-Ying Wang, You Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2025
Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment
Yue Zheng, Pengfei Zhou, Hui Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 2, 2017
Ethyl pyruvate alleviates radiation-induced lung injury in mice
Baoqing Chen, Feifei Na, Hui Yang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 14, 2021
Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients
Chengzhi Cai, Yuan Tang, Yanying Li, et al.
The Journal of Clinical Investigation
|
November 8, 2022
Integration of ER protein quality control mechanisms defines β cell function and ER architecture
Neha Shrestha, Mauricio Torres, Jason Zhang, et al.
Page
of 58
Search research articles
Search
Showing results (411-420 of 575) with videos related to
Sort By:
Page
of 58
Journal of Oncology
|
January 3, 2022
Clinicopathologic Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer
Ying Liu, Yu-Ping Zhou, Mai Zhang, et al.
Thoracic Cancer
|
October 22, 2016
Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes
Bingwen Zou, Jing Pang, Yongmei Liu, et al.
Thoracic Cancer
|
September 19, 2017
Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case-control study
Daxian Luo, Meijuan Huang, Xinxing Zhang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
April 28, 2021
Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches
Ting Mei, Weigang Xiu, Xuexi Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 29, 2025
Successful Pregnancy and Healthy Baby Outcome in a Patient With Tyrosine Kinase Inhibitor-Refractory ALK-Positive NSCLC and Central Nervous System Metastasis Treated With Lorlatinib With Maternal-Fetal Pharmacokinetics and Child Milestone Development Correlations
Zhuoran Yao, Min Tang, Ying Jin, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
October 12, 2025
Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study
Yuan Cheng, Jun-Ying Wang, You Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2025
Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment
Yue Zheng, Pengfei Zhou, Hui Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 2, 2017
Ethyl pyruvate alleviates radiation-induced lung injury in mice
Baoqing Chen, Feifei Na, Hui Yang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 14, 2021
Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients
Chengzhi Cai, Yuan Tang, Yanying Li, et al.
The Journal of Clinical Investigation
|
November 8, 2022
Integration of ER protein quality control mechanisms defines β cell function and ER architecture
Neha Shrestha, Mauricio Torres, Jason Zhang, et al.
Page
of 58